BIDE PHARMATECH revenue breakdown overview

BIDE PHARMATECH revenue for the last year amounted to 1.09 B CNY, the most of which — 471.88 M CNY — came from its highest performing source at the moment, Molecular Building Blocks Heterocyclic Compounds, the year earlier bringing 379.28 M CNY. The greatest contribution to the revenue figure was made by International — last year it brought BIDE PHARMATECH 557.05 M CNY, and the year before that — 405.55 M CNY.